Anyone else refreshing ClinicalTrials.gov every morning or just me

Curious where everyone stands on this. I have seen strong opinions both ways in other threads and want to get a proper read on the community consensus.

For context: anyone else refreshing clinicaltrials.gov every morning is something I've been going back and forth on. Some members seem to swear by one approach, others recommend the opposite.

Drop your experience below — even if it is just a quick "this worked" or "this did not work" that helps. Detailed responses obviously welcome too.

Let's get some data points going 📊

TrialNerd_Beth said:

Anyone else refreshing ClinicalTrials.gov every morning or just me

Gonna push back on this one. Anyone else refreshing is not that straightforward in my experience. I have been on this for 18 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But adherence is harder than people admit. We should be honest about that.

TrialNerd_Beth said:

Anyone else refreshing ClinicalTrials.gov every morning or just me

This is exactly right. TrialNerd_Beth articulated what I have been trying to explain to my friends for months. The Anyone else refreshing aspect is what made the difference for me.

Clinical perspective on Anyone else refreshing:

I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

denise_HTX said:

gov every morning or just meThis is exactly right

I respect denise_HTX perspective but I think this oversimplifies things a bit. Re: Anyone else refreshing — the subgroup analyses show meaningful heterogeneity.

I am not saying denise_HTX wrong entirely — just that the picture is more nuanced than a blanket statement. The SURMOUNT data specifically shows baseline BMI-dependent responses.